Why is DaVita (DVA) stock down today?
DaVita stock is down sharply after Q2 earnings beat was overshadowed by margin compression, sending shares tumbling more than 17%.
What happened
DaVita Inc. shares dropped 17.24% to $188.69 on August 5, 2026 — from a previous close of $227.99 — after the company reported second-quarter earnings that beat Wall Street's EPS estimate ($2.87 actual vs. $2.33 expected) but simultaneously revealed margin deterioration. Despite the headline earnings beat, the margin compression was enough to send the stock sharply lower in pre-market trading and continue the slide through the regular session.
The market's negative reaction illustrates a common pattern: an earnings beat alone is not sufficient if the quality of those earnings raises concerns. Investors (buyers and sellers of the stock) weighed the margin decline as a signal that profitability could face headwinds going forward, even as the dialysis provider's top-line clinical volumes showed growth. DaVita's Q2 earnings call was centered on clinical-led volume growth, but that narrative was unable to fully offset the concern around shrinking margins.
Barclays adjusted its price target on DaVita modestly higher, to $224 from $218, suggesting the sell-side saw some positive elements in the report — but the market reaction indicates the margin story dominated sentiment. The broader market provided little support on the day, with the S&P 500 (tracked by ^GSPC) down 0.17% and the Nasdaq 100 (QQQ) off 0.90%, meaning sector-wide and index-level pressure added a modest additional headwind.
DaVita had unusually high trading volume on the session and appeared among the top S&P 500 movers and gap-down stocks on Wednesday, reflecting the outsized nature of the post-earnings selloff. As of the close of Wednesday's session, shares sit at $188.69, well off the day's opening range high of $208.53 but above the intraday low of $183.62, with the market's focus now shifting to upcoming labor market data due Friday.
The catalysts, cited
What to watch next
- Non-Farm Payrolls, Average Hourly Earnings, and Unemployment Rate (August jobs report)
Moving with it
Why is DGX moving?
Why is AVTR moving?People also ask
Why is DaVita stock down so much today?
DaVita reported Q2 earnings that beat EPS estimates ($2.87 vs. $2.33 expected), but the results also showed that margins declined. The market reacted negatively to the margin compression, sending the stock down more than 17% from the prior close of $227.99.
Did DaVita beat earnings but still go down?
Yes. DaVita's Q2 EPS of $2.87 came in above the Wall Street estimate of $2.33, but the stock fell sharply because margins were down. A headline earnings beat can still lead to a selloff when the underlying profitability trend raises concerns for investors.
What did analysts say about DaVita after earnings?
Barclays adjusted its price target on DaVita upward to $224 from $218 following the results, suggesting some positive elements in the report, but the market's reaction was dominated by concern over the margin decline.
Is the whole market down today or is it just DaVita?
The broader market was only modestly lower on the day — the S&P 500 was down about 0.17% and the Nasdaq 100 was off about 0.90%. DaVita's 17% drop was driven primarily by its own earnings results, specifically the margin compression revealed in the Q2 report.